Surrogacy in HIV-1 clinical trials

被引:13
作者
Pozniak, A [1 ]
机构
[1] Univ London Kings Coll Hosp, Dept HIV & Genitourinary Med, London SE5 9RS, England
关键词
D O I
10.1016/S0140-6736(98)22008-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:536 / 537
页数:2
相关论文
共 14 条
  • [1] BABIKER A, 1997, 6 EUR C CLIN ASP TRE, P6
  • [2] Perspective: Validating surrogate markers - Are we being naive?
    DeGruttola, V
    Fleming, T
    Lin, DY
    Coombs, R
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (02) : 237 - 246
  • [3] MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL
    ECHT, DS
    LIEBSON, PR
    MITCHELL, LB
    PETERS, RW
    OBIASMANNO, D
    BARKER, AH
    ARENSBERG, D
    BAKER, A
    FRIEDMAN, L
    GREENE, HL
    HUTHER, ML
    RICHARDSON, DW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) : 781 - 788
  • [4] Surrogate end points in clinical trials: Are we being misled?
    Fleming, TR
    DeMets, DL
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) : 605 - 613
  • [5] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
    Gulick, RM
    Mellors, JW
    Havlir, D
    Eron, JJ
    Gonzalez, C
    McMahon, D
    Richman, DD
    Valentine, FT
    Jonas, L
    Meibohm, A
    Emini, EA
    Chodakewitz, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 734 - 739
  • [6] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
    Hammer, SM
    Squires, KE
    Hughes, MD
    Grimes, JM
    Demeter, LM
    Currier, JS
    Eron, JJ
    Feinberg, JE
    Balfour, HH
    Dayton, LR
    Chodakewitz, JA
    Fischl, MA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 725 - 733
  • [7] The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter
    Katzenstein, DA
    Hammer, SM
    Hughes, MD
    Gundacker, H
    Jackson, JB
    Fiscus, S
    Rasheed, S
    Elbeik, T
    Reichman, R
    Japour, A
    Merigan, TC
    Hirsch, MS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) : 1091 - 1098
  • [8] KEMPF D, 1997, 4 C RETR OPP INF WAS, P176
  • [9] Current problems and the future of antiretroviral drug trials
    Lange, JMA
    [J]. SCIENCE, 1997, 276 (5312) : 548 - 550
  • [10] Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
    Mellors, JW
    Rinaldo, CR
    Gupta, P
    White, RM
    Todd, JA
    Kingsley, LA
    [J]. SCIENCE, 1996, 272 (5265) : 1167 - 1170